
What happens when Risk Management Plans treat Australian patients as European by default? The safety implications of inadequate local adaptation. ...more
pharmacovigilance
February 08, 2026•9 min read

GMP Annex 22 sets new rules for AI in pharma manufacturing, linking with Annex 11 and Chapter 4 to define validation, data governance, and inspector expectations for compliant, explainable, and risk-b... ...more
AI in Manufacturing
October 20, 2025•6 min read



Copyright 2026. GxP Vigilance / AusAILab. All Rights Reserved.